Clinical Trials Logo

Filter by:
NCT ID: NCT05585619 Completed - Chronic Pain Clinical Trials

Difficult Encounters in Pain Medicine

Start date: October 10, 2022
Phase:
Study type: Observational

The investigators are seeking to determine factors associated with difficult patient encounters in an academic pain clinic. The investigators are examining 36 different variables to determine the association with "difficult" patient encounters as independently rated by a trainee and attending physician.

NCT ID: NCT05584657 Completed - Clinical trials for Urinary Tract Infections

Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women

REASSURE
Start date: October 18, 2022
Phase: Phase 3
Study type: Interventional

IT001-310 is a clinical study which compares the effectiveness of oral sulopenem versus oral amoxicillin/clavulanate for the treatment of adult women with uncomplicated urinary tract infection.

NCT ID: NCT05584514 Completed - Sentence Stimulus Clinical Trials

Effects of Listening Effort on Sentence Processing and Memory (Study 1)

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

Sensorineural hearing loss (SNHL) is among the most prevalent chronic conditions in aging and has a profoundly negative effect on speech comprehension, leading to increased social isolation, reduced quality of life, and increased risk for the development of dementia in older adulthood. Typical audiological tests and interventions, which focus on measuring and restoring audibility, do not explain the full range of cognitive difficulties that adults with hearing loss experience in speech comprehension. For example, adults with SNHL have to work disproportionally harder to decode acoustically degraded speech. That additional effort is thought to diminish shared executive and attentional resources for higher-level language processes, impacting subsequent comprehension and memory, even when speech is completely intelligible. This phenomenon has been referred to as listening effort (LE). There is a growing understanding that these cognitive factors are a critical and often "hidden effect" of hearing loss. At the same time, the effects of LE on the neural mechanisms of language processing and memory in SNHL are currently not well understood. In order to develop evidence-based assessments and interventions to improve comprehension and memory in SNHL, it is critical that we elucidate the cognitive and neural mechanisms of LE and its consequences for speech comprehension. In this project, we adopt a multi-method approach, combining methods from clinical audiology, psycholinguistics, and cognitive neuroscience to address this gap of knowledge. Specifically, we adopt a novel and innovative method of co-registering pupillometry (a reliable physiological measure of LE) and language-related event-related brain potential (ERP) measures during real-time speech processing to characterize the effects of acoustic challenge and LE on high-level language processes (e.g., semantic retrieval, syntactic integration) and subsequent speech memory in older adults with SNHL. This innovative work addresses a time-sensitive gap in the literature regarding the identification of objective and reliable markers of specific neurocognitive processes impacted by acoustic challenge and LE in age-related SNHL.

NCT ID: NCT05584475 Completed - ADHD Clinical Trials

Mindful Awareness Practices for ADHD Pilot Open Trial

Start date: October 5, 2022
Phase: N/A
Study type: Interventional

It is estimated that 25-40% of youth with ADHD have co-occurring cognitive disengagement syndrome (CDS; previously sluggish cognitive tempo), a set of behavioral symptoms characterized by excessive daydreaming, slowed thinking, and mental confusion and fogginess. A growing body of research demonstrates CDS to be associated with functional impairment above and beyond that which can be accounted for by ADHD severity. However, no treatment currently exists that directly targets CDS symptoms. This is a critical clinical and scientific gap, leaving youth with ADHD and co-occurring CDS at risk for experiencing negative immediate and long-term outcomes. In considering intervention approaches, mindfulness meditation involves regular practice to catch oneself when the mind wanders, and may thus an ideal intervention for youth with CDS. However, mindfulness interventions, including the Mindful Awareness Practices (MAPs) for ADHD, have never been tested in adolescents with ADHD and co-occurring CDS specifically. This study will recruit up to 15 adolescents with ADHD and co-occurring CDS symptoms to enroll in an open trial of MAPs to evaluate its feasibility, acceptability, and preliminary efficacy. Findings will provide key pilot data regarding treatment of CDS in adolescents with ADHD.

NCT ID: NCT05584189 Completed - COVID-19 Clinical Trials

COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability

Start date: October 7, 2021
Phase: N/A
Study type: Interventional

SARS-CoV-2 rapid antigen over the counter usability study.

NCT ID: NCT05584176 Completed - COVID-19 Clinical Trials

COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation

Start date: December 9, 2021
Phase: N/A
Study type: Interventional

SARS-CoV-2 rapid antigen over the counter clinical performance evaluation

NCT ID: NCT05583981 Completed - Breast Carcinoma Clinical Trials

Stakeholder Assessment of Implementing the Commission on Cancer Operative Standards for Cancer Surgery

Start date: December 1, 2021
Phase:
Study type: Observational

This study investigates the barriers to implementing breast Synoptic Operative Reports. Information from this study may help researchers identify performance objectives for the breast Synoptic Operative Reports to be adopted, implemented and continued.

NCT ID: NCT05583955 Completed - Clinical trials for Childhood-Onset Fluency Disorder

A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus)

Start date: July 25, 2022
Phase: Phase 2
Study type: Interventional

This study is designed to evaluate the effectiveness of NOE-105 on speech fluency without the known antipsychotic-induced side effects of commonly used treatments for childhood onset fluency disorder (COFD).

NCT ID: NCT05583903 Completed - Virtual Reality Clinical Trials

Usability, Acceptability, and Safety of Virtual Reality-based Cognitive Intervention

Start date: August 14, 2022
Phase: N/A
Study type: Interventional

This study aims to determine feasibility, acceptability, and usability, and to assess the safety of using a virtual reality-based software called ''ReCognitionVR'' in healthy volunteers.

NCT ID: NCT05583669 Completed - Netherton Syndrome Clinical Trials

A Study to Assess the Safety and Pharmacokinetics of Multiple Ascending Subcutaneous Doses of DS-2325a in Healthy Subjects

Start date: November 8, 2022
Phase: Phase 1
Study type: Interventional

Netherton syndrome (NS) is a rare autosomal recessive disease and no systemic treatment or standard of care currently exists for patients with NS. DS-2325a, a specific and potent inhibitor of kallikrein 5, is expected to treat NS by replacing a defective gene.